Related Experiment Video
Updated: May 19, 2026

06:12
Technical Aspects of the Mouse Aortocaval Fistula
Published on: July 11, 2013
Should functioning AV fistulas be ligated after renal transplantation?
Hillary C Yaffe1, Stuart M Greenstein
1Abdominal Organ Transplant Service, Montefiore Medical Center, Albert Einstein College of Medicine, The Bronx, NY 10467, USA.
The Journal of Vascular Access
|August 7, 2012
Summary
For successful renal transplant recipients, functioning arteriovenous fistulas (AVFs) should generally not be ligated. Persistent AVFs do not negatively impact patient or graft survival, and may be necessary if dialysis is required again.
Area of Science:
- Nephrology
- Vascular Surgery
- Transplantation Medicine
Background:
- Physicians lack clear guidelines for managing vascular accesses in renal transplant recipients.
- Arteriovenous fistulas (AVFs) are common in patients undergoing renal dialysis and transplantation.
- Decisions regarding AVF ligation in successful transplant patients are frequent and impactful.
Purpose of the Study:
- To review existing literature on arteriovenous fistula (AVF) management post-renal transplant.
- To establish guidelines for deciding whether to maintain or ligate AVFs in successful renal transplant patients.
- To address the frequent clinical question of AVF status after successful renal transplantation.
Main Methods:
- Comprehensive review of the medical literature.
- Inclusion of anecdotal clinical experience from the authors.
- Analysis of data considering 10-year adjusted renal transplant graft survival rates.
Main Results:
- The impact of AVF ligation on transplant patient cardiac morphology and function remains unclear.
- Persistent AVFs do not appear to negatively affect patient or graft survival.
- Emergent AVF closure is indicated for severe venous hypertension, pseudoaneurysm rupture risk, high-output cardiac failure, or ischemic hand.
Conclusions:
- Functioning AVFs in successful renal transplant recipients should rarely be ligated.
- Routine AVF ligation is not supported by current evidence due to potential future need for dialysis.
- Physiological impact of patent AVFs does not warrant routine ligation post-transplant.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Hemodialysis I: Introduction
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...

